MetaVia, Inc. (MTVA)
1.29
+0.06
(+4.88%)
USD |
NASDAQ |
Oct 20, 16:00
1.27
-0.02
(-1.55%)
After-Hours: 06:35
MetaVia Enterprise Value : -3.974M for Oct. 20, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 20, 2026 | -3.974M |
| October 19, 2026 | -4.369M |
| October 16, 2026 | -4.172M |
| October 15, 2026 | -3.448M |
| October 14, 2026 | -3.514M |
| October 13, 2026 | -3.054M |
| October 12, 2026 | -2.922M |
| October 09, 2026 | -3.185M |
| October 08, 2026 | -3.646M |
| October 07, 2026 | -2.856M |
| October 06, 2026 | -2.725M |
| October 05, 2026 | -2.330M |
| October 02, 2026 | -2.330M |
| October 01, 2026 | -2.330M |
| September 30, 2026 | -2.133M |
| September 29, 2026 | -1.541M |
| September 28, 2026 | -1.476M |
| September 25, 2026 | -1.541M |
| September 24, 2026 | -1.739M |
| September 23, 2026 | -1.739M |
| September 22, 2026 | -1.410M |
| September 21, 2026 | -1.476M |
| September 18, 2026 | -1.081M |
| September 17, 2026 | -2.002M |
| September 16, 2026 | -2.330M |
| Date | Value |
|---|---|
| September 15, 2026 | -2.067M |
| September 14, 2026 | -1.804M |
| September 11, 2026 | -1.541M |
| September 10, 2026 | -0.9495M |
| September 09, 2026 | -1.015M |
| September 08, 2026 | -1.278M |
| September 04, 2026 | -0.9495M |
| September 03, 2026 | -0.3577M |
| September 02, 2026 | -0.4892M |
| September 01, 2026 | -1.147M |
| August 31, 2026 | -1.147M |
| August 28, 2026 | -1.278M |
| August 27, 2026 | -1.541M |
| August 26, 2026 | -1.410M |
| August 25, 2026 | -1.673M |
| August 24, 2026 | -2.396M |
| August 21, 2026 | -2.856M |
| August 20, 2026 | -2.988M |
| August 19, 2026 | -2.791M |
| August 18, 2026 | -2.659M |
| August 17, 2026 | -2.725M |
| August 14, 2026 | -2.659M |
| August 13, 2026 | -2.856M |
| August 12, 2026 | -2.791M |
| August 11, 2026 | -3.120M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.636B |
| Alnylam Pharmaceuticals, Inc. | 30.53B |
| Anika Therapeutics, Inc. | 260.39M |
| Savara, Inc. | 835.07M |
| Vericel Corp. | 2.009B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.316M |
| Total Expenses (Quarterly) | 5.316M |
| EPS Diluted (Quarterly) | -0.8962 |
| Earnings Yield | -313.2% |
| Normalized Earnings Yield | -313.91 |